elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-744AE42D-CD65-4C25-A472-313554D480E0
Q27852097-744AE42D-CD65-4C25-A472-313554D480E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-744AE42D-CD65-4C25-A472-313554D480E0
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P433
Q27852097-744AE42D-CD65-4C25-A472-313554D480E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-744AE42D-CD65-4C25-A472-313554D480E0
rank
NormalRank
type
BestRank
Statement
P433
5
http://www.w3.org/2001/XMLSchema#string